The economic burden of major adult visual disorders in the United States.

OBJECTIVE To estimate the societal economic burden and the governmental budgetary impact of the following visual disorders among US adults aged 40 years and older: visual impairment, blindness, refractive error, age-related macular degeneration, cataracts, diabetic retinopathy, and primary open-angle glaucoma. DESIGN We estimated 3 components of economic burden: direct medical costs, other direct costs, and productivity losses. We used private insurance and Medicare claims data to estimate direct medical costs; epidemiologic evidence from multiple published sources to estimate other direct costs, such as nursing home costs; and data from the Survey of Income and Program Participation to estimate productivity losses. We used budgetary documents and our direct medical and other direct cost estimates to approximate the governmental budgetary impact. RESULTS We estimated that the annual total financial burden of major adult visual disorders is $35.4 billion ($16.2 billion in direct medical costs, $11.1 billion in other direct costs, and $8 billion in productivity losses) and that the annual governmental budgetary impact is $13.7 billion. CONCLUSIONS Major visual disorders among Americans older than 40 years result in substantial economic costs for the US economy. Well-designed public health programs may have the ability to reduce this burden in the future.

[1]  Anmar M. A. Rahman,et al.  Early paracentral visual field loss in patients taking hydroxychloroquine. , 2006, Archives of ophthalmology.

[2]  Mary Frances Picciano,et al.  Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. , 2004, American journal of epidemiology.

[3]  R. Klein,et al.  Causes and prevalence of visual impairment among adults in the United States. , 2004, Archives of ophthalmology.

[4]  Paul Mitchell,et al.  The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. , 2004, Archives of ophthalmology.

[5]  U. C. Bureau Statistical Abstract of the United States , 2004 .

[6]  Thomas Fleming,et al.  Red book : pharmacy's fundamental reference , 2004 .

[7]  Frank A Sloan,et al.  Longitudinal rates of annual eye examinations of persons with diabetes and chronic eye diseases. , 2003, Ophthalmology.

[8]  Paul P. Lee,et al.  Estimates of incidence rates with longitudinal claims data. , 2003, Archives of ophthalmology.

[9]  Frank A Sloan,et al.  Longitudinal prevalence of major eye diseases. , 2003, Archives of ophthalmology.

[10]  R. Fiscella,et al.  Medical therapy cost considerations for glaucoma. , 2003, American journal of ophthalmology.

[11]  M. F. Smith,et al.  Glaucoma Medical Treatment—2002: Does Yearly Cost Now Equal the Year? , 2002, Optometry and vision science : official publication of the American Academy of Optometry.

[12]  L. Ellwein,et al.  Use of eye care and associated charges among the Medicare population: 1991-1998. , 2002, Archives of ophthalmology.

[13]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[14]  H. Taylor,et al.  Visual impairment and eye diseases in elderly institutionalized Australians. , 2000, Ophthalmology.

[15]  C. Gabrel Characteristics of elderly nursing home current residents and discharges: data from the 1997 National Nursing Home Survey. , 2000, Advance data.

[16]  R G Fiscella,et al.  Cost considerations of medical therapy for glaucoma. , 1999, American journal of ophthalmology.

[17]  P. Mitchell,et al.  Refractive errors in an older population: the Blue Mountains Eye Study. , 1999, Ophthalmology.

[18]  Lomb Memorial,et al.  Office of Special Education and Rehabilitative Services , 1997 .

[19]  A. Sommer,et al.  The prevalence of blindness and visual impairment among nursing home residents in Baltimore. , 1995, The New England journal of medicine.

[20]  R. Klein,et al.  Refractive status in the Beaver Dam Eye Study. , 1994, Investigative ophthalmology & visual science.

[21]  Joanne Katz,et al.  Blindness and Visual Impairment in an American Urban Population-Reply , 1990 .

[22]  D. Snydacker,et al.  Blindness and visual impairment in an American urban population. , 1990, Archives of ophthalmology.

[23]  J Katz,et al.  Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. , 1990, Archives of ophthalmology.

[24]  S. Wilson Methods for the economic evaluation of health care programmes , 1987 .